Pharmaceuticals
Disappointing News on INNs from the FDA
You may recall I have written about the World Health Organization’s (WHO) naming system for drugs, called the International Non-Proprietary Name or INN, in a January 15, 2015 Swine Line
Howard Dean is Correct
It is not too often that I agree with former Vermont Governor and Democratic presidential candidate Howard Dean but when it comes to the government “negotiating” drug prices in Medicare Part D, he is correct.
More Proof the 340B Program Needs Reform
A July 6, 2015 GAO report confirms that reform of the 340B program is necessary.
Why is FOX Business News Pushing Price Controls?
It was the headline on the FOX Business News April 27 article that captured my attention. It said, “More Government Waste Found at Medicare.” I thought, well, what else is new, it’s pretty much a governmen
340B Drug Discount Program Finally Gets a Congressional Hearing
House Energy and Commerce Subcommittee on Health holds first hearing on the 340B drug discount program since 2005.
Newt's Very Bad Idea
Former House Speaker Newt Gingrich often comes up with ideas to change how the government works. One of his most recent suggestions has made a lot of people who care about property rights scratch their head.
See You In Court - Again
One of the things that is becoming more disturbing each day is how the Obama Administration is issuing a tsunami of regulations, interpretive rules, sub-regulatory guidance, executive orders, guidelines, and even divine proclamations on White House...
What is the 340B Program and Why You Need to Care
Problems in the 340B drug discount program are growing and costs are increasing due as more entities participate in the program.
